Congenital Heart Defects

Launched by ASSIUT UNIVERSITY · Nov 5, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the connection between maternal diabetes and congenital heart defects in newborns. Specifically, it looks at infants born to mothers who have diabetes compared to infants born to mothers who do not have diabetes. The aim is to understand how diabetes in mothers might affect their babies' heart health, especially those who need special care in the Neonatal Intensive Care Unit (NICU) or outpatient clinics at Assiut University Children's Hospital.

To participate in the study, infants must be born to either diabetic or non-diabetic mothers and should not have been previously checked for heart defects. The trial will not include infants exposed to other risk factors for heart defects, like certain infections or medications. While the study is not yet recruiting participants, those involved can expect to contribute to important research that could help improve care for infants with congenital heart conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • The study will include infants of diabetic mothers and infants of non-diabetic mothers not previously screened for congenital heart defects.
• Exclusion Criteria:
• • Other risk factors for congenital heart defects including congenital infections like TORCH infection, teratogenic drugs ( lithium or isotretinoin), , alcohol, or smoking.